3 Hospital Chain, Specialty Chemicals Maker and Steam Turbines Maker Stocks With a Strong Future Roadmap: Narayana Hrudayalaya, Atul and Triveni Turbine
- November 12, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Narayana Hrudayalaya, Atul and Triveni Turbine: ROE of 10.9% to 24.2% and FY22 to FY26 revenue CAGR of 5.9% to 26.5%. Prices as of 11 Nov 2026.
Quick Answer
The three hospital, specialty chemical and turbine stocks to watch are Narayana Hrudayalaya, Atul and Triveni Turbine. Their return on equity ranges from 10.9% to 24.2%, and their revenue compound annual growth from FY22 to FY26 ranges from 5.9% to 26.5%. Triveni Turbine leads on both return on equity at 24.2% and revenue growth at 26.5% a year. Prices are based on the 11 November 2026 close, and this article is educational, not investment advice.
Hospital, specialty chemical and turbine stocks give investors a way to track businesses that sit close to everyday demand in India. Narayana Hrudayalaya, Atul and Triveni Turbine cover a hospital chain, a specialty chemicals maker and a steam turbines maker.
This list covers three hospital, specialty chemical and turbine stocks with complete current figures: Narayana Hrudayalaya, Atul and Triveni Turbine. Every figure comes from the latest reported financials and the 11 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Hospital, Specialty Chemical and Turbine Stocks?
Hospital, specialty chemical and turbine stocks are listed companies that run multi speciality hospitals with a focus on heart care, make aromatics, intermediates and crop chemicals, and build steam turbines for industry and power. Their earnings depend on patient volumes, chemical demand and turbine orders.
Hospital, Specialty Chemical and Turbine Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Narayana Hrudayalaya | 1,866.4 | 35,603 | 43.6 | 59.6 | 17.8 | 1.29 |
| Atul | 5,246 | 17,898 | 22.1 | 35.1 | 10.9 | 0.03 |
| Triveni Turbine | 514.35 | 15,418 | 45.9 | 43.9 | 24.2 | 0.02 |
On valuation, Narayana Hrudayalaya and Atul trade at a P/E below the industry P/E, while Triveni Turbine trades above it, which reflects the growth the market already expects. Readers comparing hospital, specialty chemical and turbine stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.
Why Do Hospital, Specialty Chemical and Turbine Stocks Have a Strong Roadmap in India?
Hospital, specialty chemical and turbine stocks have a strong roadmap in India because rising need for quality hospital care, wider use of specialty chemicals and growing industrial captive power keep widening the market for these companies.
- Hospitals. Families seek quality specialist care.
- Specialty chemicals. Industry uses advanced chemical inputs.
- Steam turbines. Factories add captive power capacity.
Why Narayana Hrudayalaya Features Among These Hospital, Specialty Chemical and Turbine Stocks
Among the hospital, specialty chemical and turbine stocks on this list, Narayana Hrudayalaya, widely known as Narayana Health, is a Bengaluru-based hospital group built around affordable cardiac care that now covers multiple specialities across India and also operates in the Cayman Islands.
Revenue rose from Rs 3,736 crore in FY22 to Rs 7,996 crore in FY26, a compound annual growth rate of 21.0%. Net profit grew from Rs 342 crore in FY22 to Rs 810 crore in FY26, which works out to a compound annual growth rate of 24.1%.
The company has a return on equity of 17.8%, a debt to equity ratio of 1.29 and a market capitalisation of Rs 35,603 crore. The stock trades at a P/E of 43.6, below the industry P/E of 59.6.
Roadmap: Growth is coming from bed additions across its hospital clusters, a rising share of higher-value specialities and an expanding insurance-led patient base. The group has a track record of running hospitals at high efficiency, which supports margins as scale builds.
What to watch: Keep an eye on occupancy in newly added beds and the payor mix between insurance and cash patients.
Why Atul Features Among These Hospital, Specialty Chemical and Turbine Stocks
Among the cardiac care, dye chemical and steam machine shares on this list, Atul is a Gujarat-based chemical company with life science chemicals for crop protection and pharmaceuticals, and performance and other chemicals that include aromatics, colours and polymers.
The company has a return on equity of 10.9%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 17,898 crore. The stock trades at a P/E of 22.1, below the industry P/E of 35.1.
Revenue rose from Rs 5,157 crore in FY22 to Rs 6,476 crore in FY26, a compound annual growth rate of 5.9%. Net profit grew from Rs 507 crore in FY23 to Rs 689 crore in FY26, which works out to a compound annual growth rate of 10.8%. In the June 2026 quarter, revenue grew 25.1% year on year to Rs 1,881 crore, while net profit rose 91.8% to Rs 254 crore.
Roadmap: The company supplies many industries from a single integrated site and has been adding capacity in higher-value chemicals. A broad product basket across agriculture, pharma and consumer uses spreads demand.
What to watch: Check capacity additions and demand in agrochemical and pharmaceutical intermediates.
Why Triveni Turbine Features Among These Hospital, Specialty Chemical and Turbine Stocks
Among the three companies on this list, Triveni Turbine designs and manufactures steam turbines up to 100 MW for industrial power, sugar, biomass and waste-to-energy plants, and has a large aftermarket business.
Revenue rose from Rs 882 crore in FY22 to Rs 2,258 crore in FY26, a compound annual growth rate of 26.5%. Net profit grew from Rs 270 crore in FY22 to Rs 349 crore in FY26, which works out to a compound annual growth rate of 6.6%.
In the June 2026 quarter, revenue grew 19.7% year on year to Rs 471 crore. The company has a return on equity of 24.2%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 15,418 crore. The stock trades at a P/E of 45.9, above the industry P/E of 43.9.
Roadmap: Its roadmap includes new product platforms, a rising share of exports and a growing aftermarket franchise that brings recurring revenue. A healthy order book gives visibility into the coming quarters, and a debt-free balance sheet supports expansion.
What to watch: Track order inflows, since turbine deliveries follow orders with a lag.
Narayana Hrudayalaya vs Atul vs Triveni Turbine on Key Financials
The table below sets the three hospital, specialty chemical and turbine stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Narayana Hrudayalaya | 3,736 | 7,996 | 21.0% | 810 | 10.1% |
| Atul | 5,157 | 6,476 | 5.9% | 689 | 10.6% |
| Triveni Turbine | 882 | 2,258 | 26.5% | 349 | 15.5% |
Triveni Turbine posts the highest return on equity in this group at 24.2%. Narayana Hrudayalaya has the largest FY26 revenue at Rs 7,996 crore, and Triveni Turbine shows the fastest revenue growth with a 26.5% compound annual rate. A useful habit with hospital, specialty chemical and turbine stocks is to check each new quarterly result against the capacity plans the company described earlier.
Key Risks to Check Before Investing in Hospital, Specialty Chemical and Turbine Stocks
Every theme carries risks that deserve a check before any decision. For these hospital, specialty chemical and turbine stocks, the main points are: Long-term cardiac care, dye chemical and steam machine shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Capacity ramp up. New hospitals take time to fill beds and reach full returns.
- Raw material and energy costs. Input prices can move margins in chemicals.
- Order timing. Project awards can shift between periods.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter hospital, specialty chemical and turbine stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Hospital, Specialty Chemical and Turbine Stocks
Hospital, specialty chemical and turbine stocks work best when investors track growth, valuation and return on equity side by side. Narayana Hrudayalaya, Atul and Triveni Turbine each have a clear plan to grow. Based on the 11 November 2026 close, Narayana Hrudayalaya trades at Rs 1,866.4, Atul at Rs 5,246 and Triveni Turbine at Rs 514.35.
Download the Univest iOS App or Univest Android App to track hospital, specialty chemical and turbine stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are hospital, specialty chemical and turbine stocks?
Ans. Hospital, specialty chemical and turbine stocks are listed companies that run multi speciality hospitals with a focus on heart care, make aromatics, intermediates and crop chemicals, and build steam turbines for industry and power. Their earnings depend on patient volumes, chemical demand and turbine orders. This list looks at three of them, Narayana Hrudayalaya, Atul and Triveni Turbine, using reported FY22 to FY26 financials and the 11 November 2026 closing prices.
Which hospital, specialty chemical and turbine stocks are covered in this list?
Ans. This list covers Narayana Hrudayalaya, Atul and Triveni Turbine. Based on the 11 November 2026 close, Narayana Hrudayalaya traded at Rs 1,866.4, Atul at Rs 5,246 and Triveni Turbine at Rs 514.35. Their return on equity ranges from 10.9% to 24.2%, and their revenue compound annual growth from FY22 to FY26 ranges from 5.9% to 26.5%.
Why do hospital, specialty chemical and turbine stocks have a strong future roadmap in India?
Ans. Hospital, specialty chemical and turbine stocks have a strong roadmap in India because rising need for quality hospital care, wider use of specialty chemicals and growing industrial captive power keep widening the market for these companies. The main drivers are as follows. Hospitals. Families seek quality specialist care. Specialty chemicals. Industry uses advanced chemical inputs. Steam turbines. Factories add captive power capacity. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Narayana Hrudayalaya performed financially?
Ans. Revenue rose from Rs 3,736 crore in FY22 to Rs 7,996 crore in FY26, a compound annual growth rate of 21.0%. Net profit grew from Rs 342 crore in FY22 to Rs 810 crore in FY26, which works out to a compound annual growth rate of 24.1%. The company has a return on equity of 17.8%, a debt to equity ratio of 1.29 and a market capitalisation of Rs 35,603 crore. The stock trades at a P/E of 43.6, below the industry P/E of 59.6. Looking ahead, growth is coming from bed additions across its hospital clusters, a rising share of higher-value specialities and an expanding insurance-led patient base. The group has a track record of running hospitals at high efficiency, which supports margins as scale builds.
How has Atul performed financially?
Ans. Revenue rose from Rs 5,157 crore in FY22 to Rs 6,476 crore in FY26, a compound annual growth rate of 5.9%. Net profit grew from Rs 507 crore in FY23 to Rs 689 crore in FY26, which works out to a compound annual growth rate of 10.8%. In the June 2026 quarter, revenue grew 25.1% year on year to Rs 1,881 crore, while net profit rose 91.8% to Rs 254 crore. The company has a return on equity of 10.9%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 17,898 crore. The stock trades at a P/E of 22.1, below the industry P/E of 35.1. Looking ahead, the company supplies many industries from a single integrated site and has been adding capacity in higher-value chemicals. A broad product basket across agriculture, pharma and consumer uses spreads demand.
How has Triveni Turbine performed financially?
Ans. Revenue rose from Rs 882 crore in FY22 to Rs 2,258 crore in FY26, a compound annual growth rate of 26.5%. Net profit grew from Rs 270 crore in FY22 to Rs 349 crore in FY26, which works out to a compound annual growth rate of 6.6%. In the June 2026 quarter, revenue grew 19.7% year on year to Rs 471 crore. The company has a return on equity of 24.2%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 15,418 crore. The stock trades at a P/E of 45.9, above the industry P/E of 43.9. Looking ahead, its roadmap includes new product platforms, a rising share of exports and a growing aftermarket franchise that brings recurring revenue. A healthy order book gives visibility into the coming quarters, and a debt-free balance sheet supports expansion.
What risks should investors check before buying hospital, specialty chemical and turbine stocks?
Ans. Investors should check a few risks before buying hospital, specialty chemical and turbine stocks. Capacity ramp up. New hospitals take time to fill beds and reach full returns. Raw material and energy costs. Input prices can move margins in chemicals. Order timing. Project awards can shift between periods. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of hospital, specialty chemical and turbine stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 11 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.